Victory Capital Management Inc Agios Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $98.4 Billion
  • Q1 2024

A detailed history of Victory Capital Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 7,210 shares of AGIO stock, worth $310,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,210
Holding current value
$310,895
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$21.32 - $34.81 $153,717 - $250,980
7,210 New
7,210 $210,000
Q1 2023

May 02, 2023
SELL
$21.74 - $30.93 $18.1 Million - $25.8 Million
-834,624 Reduced 94.06%
52,670 $1.21 Million
Q4 2022

Feb 09, 2023
BUY
$24.81 - $31.52 $2.73 Million - $3.47 Million
109,998 Added 14.15%
887,294 $24.9 Million
Q3 2022

Nov 02, 2022
BUY
$19.51 - $34.14 $15.2 Million - $26.5 Million
777,296 New
777,296 $22 Million
Q1 2022

May 04, 2022
SELL
$26.68 - $34.81 $326,216 - $425,621
-12,227 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$29.58 - $49.78 $1.21 Million - $2.04 Million
-40,899 Reduced 76.98%
12,227 $402,000
Q3 2021

Nov 02, 2021
BUY
$41.92 - $58.18 $1.9 Million - $2.64 Million
45,364 Added 584.44%
53,126 $2.45 Million
Q2 2021

Aug 03, 2021
SELL
$52.06 - $61.27 $55,079 - $64,823
-1,058 Reduced 12.0%
7,762 $428,000
Q1 2021

May 04, 2021
SELL
$44.23 - $57.5 $10,172 - $13,225
-230 Reduced 2.54%
8,820 $455,000
Q4 2020

Feb 01, 2021
BUY
$33.21 - $46.54 $45,165 - $63,294
1,360 Added 17.69%
9,050 $392,000
Q3 2020

Nov 09, 2020
BUY
$33.87 - $55.93 $5,419 - $8,948
160 Added 2.12%
7,690 $269,000
Q2 2020

Aug 07, 2020
SELL
$34.45 - $53.48 $2,273 - $3,529
-66 Reduced 0.87%
7,530 $403,000
Q1 2020

May 04, 2020
SELL
$31.52 - $53.81 $61,527 - $105,037
-1,952 Reduced 20.44%
7,596 $270,000
Q4 2019

Feb 06, 2020
BUY
$30.08 - $50.59 $58,204 - $97,891
1,935 Added 25.42%
9,548 $456,000
Q4 2019

Feb 04, 2020
BUY
$30.08 - $50.59 $28,666 - $48,212
953 Added 14.31%
7,613 $371,000
Q3 2019

Nov 12, 2019
BUY
$32.4 - $49.58 $215,784 - $330,202
6,660 New
6,660 $216,000

Others Institutions Holding AGIO

# of Institutions
207
Shares Held
60M
Call Options Held
365K
Put Options Held
457K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.36B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email